EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Epigenetic and biogenetic regulation by polyphenols in prostate cancer in the context of 3P medicine

Huke Dong, Chen Zhang

EPMA Journal · 21.12.2024 · 16 (1) · 113-125

DOI: 10.1007/s13167-024-00391-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EPMA Journal, online erschienen am 21.12.2024. Verfasst von Huke Dong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Anhui Province, Hefei City, 230000 China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) can remain asymptomatic for years, complicating early detection and effective intervention. Predictive, Preventive, and Personalized Medicine (3PM) provides a transformative framework for addressing these challenges by integrating novel biomarkers, targeted prevention, and individualized therapies. Recent studies highlight the pivotal role of dysregulated microRNAs (miRNAs) and epigenetic alterations in cancer progression and metastasis. miRNAs, as non-coding RNAs approximately 22 nucleotides in length, regulate gene expression through translational inhibition or mRNA degradation. Dysregulated miRNAs are linked to the overexpression of oncogenic proteins and suppression of tumor suppressor genes in malignancies. Polyphenols such as curcumin, quercetin, resveratrol, and green tea catechins (EGCG) have demonstrated potential in modulating miRNA expression and reversing aberrant epigenetic modifications. Despite their established anticancer effects, the clinical application of polyphenols in stratified patient groups, particularly in primary and secondary cancer prevention, remains underexplored. Beyond their anti-inflammatory and antioxidant properties, polyphenols modulate early epigenetic and biogenetic events critical for cancer prevention and therapy. By targeting predictive biomarkers and improving therapy response, polyphenols contribute significantly to 3PM by enabling early diagnostics, mitigating risks, and personalizing treatments. This review evaluates current knowledge of polyphenols' impact on miRNAs and epigenetics in PCa and explores their potential applications within the 3PM framework, emphasizing predictive diagnostics, targeted prevention, and personalized treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

Anti-inflammatory and antioxidant propertiesApoptosisCancer progression and metastasisCurcuminDNA methylationEpigenetic regulationGreen teaMiRNAsOncologyPolyphenolsPredictive, Preventive, and Personalized Medicine (3PM / PPPM)Prostate cancerQuercetinResveratrolRisk mitigation

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Anhui Province, Hefei City, 230000 China.
  • The First Clinical Medical College, The First Affiliated of Anhui University of Traditional Chinese Medicine, Anhui Province, Hefei City, 230000 China.

Zitieren

APA

Dong, H., & Zhang, C. (2024). Epigenetic and biogenetic regulation by polyphenols in prostate cancer in the context of 3P medicine. EPMA Journal, 16(1), 113-125. https://doi.org/10.1007/s13167-024-00391-3

Vancouver

Dong H, Zhang C. Epigenetic and biogenetic regulation by polyphenols in prostate cancer in the context of 3P medicine. EPMA Journal. 2024;16(1):113-125. doi:10.1007/s13167-024-00391-3

BibTeX
@article{Dong2024,
  author = {Dong, Huke and Zhang, Chen},
  title = {Epigenetic and biogenetic regulation by polyphenols in prostate cancer in the context of 3P medicine},
  journal = {EPMA Journal},
  year = {2024},
  volume = {16},
  number = {1},
  pages = {113--125},
  doi = {10.1007/s13167-024-00391-3}
}
Kostenlos starten →